Condition
Vaginal Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 18 Vaginal Cancer clinical trials that are recruiting, at sites in 7 countries (most in United States (9), China (4), Poland (1)). 2 were first registered in the last 30 days. By phase: Phase 2 (3), Phase 1 (1), Phase 3 (1), Phase 1/2 (1). The most active sponsors are Rutgers, The State University of New Jersey (2), Shanghai Bovax Biotechnology Co., Ltd. (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 18Clinical trials
- 2New in 30 days
- 7Countries
Newest Vaginal Cancer clinical trials
All recruiting trials (18)
-
Methylation markers in self-samples to help detect gynecological cancers
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation or other genetic markers that indicate endometrial, ovarian, vulvar, or vaginal cancers in women who are at risk or have postmenopausal bleeding.
-
Radiotherapy for gynecologic cancer with up to 10 metastatic sites
This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.
-
Vagina-View helps guide multichannel applicator placement during vaginal brachytherapy
This study tests whether the Vagina-View device can visualize vaginal tumors and help place the MCA more precisely during brachytherapy for vaginal cancer.
-
Testing trastuzumab deruxtecan (T‑DxD) for HER2‑positive advanced solid tumors
This will test whether trastuzumab deruxtecan (T‑DxD) helps adults in the US with HER2‑positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have had prior systemic treatment and have no satisfactory alternative options.
-
Using Belzutifan to treat recurrent clear cell ovarian carcinoma
This study is testing if a new targeted therapy called Belzutifan can help people with recurrent clear cell ovarian cancer feel better and manage their disease.
-
Using SCG142 TCR-T cells to treat HPV-related cancers
This study is testing a new type of immune cell treatment called SCG142 TCR-T cells to see if it can help people with advanced cancers related to HPV.
-
3D printed applicators for treating gynecologic cancers
This study is testing whether 3D-printed custom applicators can make radiation treatment more effective for patients with gynecologic cancers.
-
Evaluating radiochemotherapy and interventional radiotherapy for vaginal cancer
This study is testing a new treatment plan that combines radiation and chemotherapy for people with vaginal cancer to see if it helps them live longer and control the disease better.
-
Biobank for studying ALS and Alzheimer's diseases
This study is collecting blood, skin samples, and health information from people to see how genetics might help us understand and find treatments for ALS and Alzheimer's disease.
-
Reiki therapy to help patients with gynecological cancers undergoing brachytherapy
This study tests if Reiki therapy can help reduce anxiety, pain, and depression in women with gynecological cancers who are about to start brachytherapy.
-
Immunotherapy using E7 TCR-T cells for HPV-related cancers
This study is testing a new immunotherapy using E7 TCR-T cells to see if it can help people with advanced HPV-related cancers like cervical and throat cancer feel better and improve their health.
-
E7 T-cell therapy for advanced HPV-related cancers
This study is testing a new treatment using specially modified immune cells to see if it can help people with advanced cancers linked to HPV feel better and live longer.
-
Assessing immune response after HPV vaccination in women
This study is testing how long the immune protection lasts in Chinese women aged 9-45 after they complete the full HPV vaccination schedule.
-
Examining the effects of brachytherapy on gynecological cancers
This study looks at how well brachytherapy works for women aged 18 to 80 with different types of gynecological cancers.
-
Evaluating a 9-valent HPV vaccine in healthy Chinese women
This study is testing a new 9-valent HPV vaccine in healthy Chinese women aged 20-45 to see how well it works and if it's safe for preventing HPV-related cancers.
-
Using MRI to improve gynecologic cancer treatment with brachytherapy
This study is testing if using MRI instead of traditional CT scans can help improve brachytherapy treatment for women with gynecologic cancers by better targeting tumors and reducing radiation exposure to healthy tissues.
-
A resource for collecting cancer data and biospecimens
This study is creating a resource to collect health information and samples from cancer patients and healthy individuals to help improve cancer prevention and treatment strategies.
-
Collecting specimens and data for early detection and prevention of ovarian cancer
This study is trying to find better ways to detect and prevent ovarian cancer early by collecting blood and tissue samples from people at high risk.
Related topics
Quick answers
How many Vaginal Cancer clinical trials are recruiting right now?
18, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (9 trials), China (4 trials), Poland (1 trial), Australia (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 1, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.